Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−19.39 USD
−31.48 M USD
0.00 USD
1.28 M
About Forte Biosciences, Inc.
Sector
Industry
CEO
Paul A. Wagner
Website
Headquarters
Dallas
Founded
2017
FIGI
BBG001J2N4H0
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of FBRX is 23.05 USD — it has increased by 8.06% in the past 24 hours. Watch Forte Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Forte Biosciences, Inc. stocks are traded under the ticker FBRX.
FBRX stock has risen by 48.48% compared to the previous week, the month change is a 429.79% rise, over the last year Forte Biosciences, Inc. has showed a 88.16% increase.
We've gathered analysts' opinions on Forte Biosciences, Inc. future price: according to them, FBRX price has a max estimate of 150.00 USD and a min estimate of 64.00 USD. Watch FBRX chart and read a more detailed Forte Biosciences, Inc. stock forecast: see what analysts think of Forte Biosciences, Inc. and suggest that you do with its stocks.
FBRX reached its all-time high on May 8, 2017 with the price of 6,732.30 USD, and its all-time low was 4.11 USD and was reached on Nov 1, 2024. View more price dynamics on FBRX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FBRX stock is 11.65% volatile and has beta coefficient of 1.31. Track Forte Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Forte Biosciences, Inc. there?
Today Forte Biosciences, Inc. has the market capitalization of 34.30 M, it has increased by 167.81% over the last week.
Yes, you can track Forte Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Forte Biosciences, Inc. is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
FBRX earnings for the last quarter are −4.54 USD per share, whereas the estimation was −6.33 USD resulting in a 28.32% surprise. The estimated earnings for the next quarter are −2.74 USD per share. See more details about Forte Biosciences, Inc. earnings.
Forte Biosciences, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
FBRX net income for the last quarter is −8.39 M USD, while the quarter before that showed −12.51 M USD of net income which accounts for 32.92% change. Track more Forte Biosciences, Inc. financial stats to get the full picture.
No, FBRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 3, 2024, the company has 9.00 employees. See our rating of the largest employees — is Forte Biosciences, Inc. on this list?
Like other stocks, FBRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Forte Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Forte Biosciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Forte Biosciences, Inc. stock shows the neutral signal. See more of Forte Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.